Pettit, MD, and participants discussed second-line considerations in high-risk polycythemia after hydroxyurea failure.
Neo7Bioscience Announces Precision Signal Interception for Pancreatic Cancer Treatment Beyond Conventional RAS Pathway Suppression ...